Next Big Step: SK Bioscience Gears Up For Endemic COVID, Next Pandemic

Aggressive M&A Part Of Growth Strategy

SK Bioscience CEO Jae-Yong Ahn
SK Bioscience Eyes Big Jump In Growth In Coming Years • Source: SK Bioscience
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia